An Update on Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
Over the past two decades, treatment of multiple myeloma (MM) has advanced dramatically. However, despite the introduction of several lines of novel therapeutics, autologous hematopoietic stem cell transplantation (HSCT) followed by maintenance therapy is the current standard of care in transplant e...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2023
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/85327 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: An Update on Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
- Outpatient Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
- Proteasome Inhibition and Hematopoietic Stem Cell Transplantation in Multiple Myeloma
- Multiple Myeloma in the Era of Novel Agents and Stem Cell Therapies
- Introductory Chapter: Update on Multiple Myeloma
- Hematopoietic Stem Cell Transplantation in HIV Infected Patients
- The Current Role of Stem Cell Transplantation in Multiple Myeloma